Rani Therapeutics Holdings recently announced a collaboration and license agreement with Chugai Pharmaceutical for the joint development and commercialization of an oral product combining Rani’s ...

The company will receive an upfront payment of $10 million. It could also earn up to $75 million in development milestones, $100 million in sales milestones, and single-digit royalties on future ...

Kate Hudson's seven-year-old daughter Rani Rose got her ears pierced. The Running Point actress proudly filmed the milestone and later posted the video on TikTok. Hudson shares Rani with her longtime ...

Social media influencer Aarush Bhola, who finished as the first runner-up on Rise And Fall, addressed the rumours surrounding his relationship with fellow contestant Manisha Rani. Post his exit from ...

MUMBAI- Keeping up with the tradition, actresses Rani Mukerji and Kajol were seen indulging in the festivities during their visit to the Puja pandal on September 27. Kajol looked as stunning as ever ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Rajasthani Kadhi is a beloved regional variation of the classic Indian kadhi, celebrated for its tangy yoghurt base and robust flavours from roasted gram flour. Unlike other kadhi versions, the ...

(Reuters) -Rani Therapeutics on Friday announced a licensing deal to develop an oral version of Chugai Pharmaceutical's experimental antibody, with an option to extend it to up to five drugs, ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

While considering a marriage alliance, the Hindu custom does not allow the tying of the knot until the ten poruthams are studied and matched for the couple who desires to be joined in matrimony.

Stock futures inched higher on Monday, with a wave of major earnings reports and ongoing U.S.-China trade tensions in focus this week.